If taken with insulin or an insulin secretagogue (e.g., sulfonylurea), it is best to talk to your health care provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia
Provided as lyophilized powder requiring reconstitution with bacteriostatic water
Semaglutide, tirzepatide, and retatrutide attenuate the interoceptive effects of alcohol in male and female rats
Compare this approach to the standard semaglutide dosing chart in units to see how Strive schedule aligns with conventional protocols
Mass Spectrometry (MS): This confirms the identity of the peptide by measuring its molecular weight
Stomach Pain on Reta vs Other GLP-1 Compounds Cross-trial comparisons have significant limitations, but directional data helps contextualize the stomach pain experience on retatrutide: Metric Retatrutide 12 mg Semaglutide 2.4 mg Tirzepatide 15 mg Overall GI events ~67% ~74% ~51% Nausea ~46% ~44% ~31% Diarrhea ~33% ~30% ~23% Vomiting ~22% ~24% ~12% Discontinuation due to GI AEs ~8% ~7% ~6% Key observation: Despite targeting three receptors instead of one or two, retatrutide's overall GI adverse event rate is comparable to semaglutide and modestly higher than tirzepatide